Cite
Cytokeratin (AE1/AE3) in addition to α-methylacyl coenzyme A racemase (P504S), 34-beta-E12, and p63 stains in evaluation of surgical specimens after hormonal therapy for prostatic adenocarcinoma.
MLA
Raspollini, Maria Rosaria. “Cytokeratin (AE1/AE3) in Addition to α-Methylacyl Coenzyme A Racemase (P504S), 34-Beta-E12, and P63 Stains in Evaluation of Surgical Specimens after Hormonal Therapy for Prostatic Adenocarcinoma.” Human Pathology, vol. 39, no. 2, Feb. 2008, pp. 304–05. EBSCOhost, https://doi.org/10.1016/j.humpath.2007.10.018.
APA
Raspollini, M. R. (2008). Cytokeratin (AE1/AE3) in addition to α-methylacyl coenzyme A racemase (P504S), 34-beta-E12, and p63 stains in evaluation of surgical specimens after hormonal therapy for prostatic adenocarcinoma. Human Pathology, 39(2), 304–305. https://doi.org/10.1016/j.humpath.2007.10.018
Chicago
Raspollini, Maria Rosaria. 2008. “Cytokeratin (AE1/AE3) in Addition to α-Methylacyl Coenzyme A Racemase (P504S), 34-Beta-E12, and P63 Stains in Evaluation of Surgical Specimens after Hormonal Therapy for Prostatic Adenocarcinoma.” Human Pathology 39 (2): 304–5. doi:10.1016/j.humpath.2007.10.018.